---
figid: PMC4676894__12943_2015_474_Fig3_HTML
figtitle: Oncogenic (deregulated) intracellular signaling pathways in activated B
  cell-like (ABC) diffuse large B-cell lymphoma (DLBCL)
organisms:
- Homo sapiens
pmcid: PMC4676894
filename: 12943_2015_474_Fig3_HTML.jpg
figlink: /pmc/articles/PMC4676894/figure/Fig3/
number: F3
caption: 'Oncogenic (deregulated) intracellular signaling pathways in activated B
  cell-like (ABC) diffuse large B-cell lymphoma (DLBCL). The oncogenic constitutive
  activation of canonical nuclear factor-kappa B (NF-κB) family members in activated
  B cell-like diffuse large B-cell lymphoma (ABC-DLBCL), together with a blockade
  in terminal B cell differentiation, which is in part mediated by BCL6, represent
  the hallmarks of ABC-DLBCL pathogenesis [, –, ]. The different colors that are used
  in the figure indicate molecules that belong to a specific pathway and/or lead to
  a specific outcome. Adapted from REF: [, , , ]. Information for this figure was
  gleaned from the following references: [, , , , –, , , , , , –, , , , , , –, , ,
  , , , , , , , , , , –, –, , , , , –, –, –, , , , , –, –, , , ]. Abbreviations: BCR
  B cell receptor, BTK Bruton’s tyrosine kinase, SYK spleen tyrosine kinase, PI3K
  phosphoinositide 3-kinase, mTORC1 mammalian target of rapamycin (mTOR) complex 1,
  CD40L CD40 ligand, JAK Janus kinase, IRF4 interferon-regulatory factor 4, MALT1
  mucosa-associated lymphoid tissue lymphoma translocation protein 1, BCL10 B cell
  lymphoma protein 10, TLR Toll-like receptor, MyD88 myeloid differentiation primary
  response 88, CARD11 caspase recruitment domain family, member 11, PKCβ protein kinase
  Cβ, STAT3 signal transducer and activator of transcription 3, BCL6 B cell lymphoma
  protein 6, BCL2 B cell lymphoma protein 2'
papertitle: 'Novel drug targets for personalized precision medicine in relapsed/refractory
  diffuse large B-cell lymphoma: a comprehensive review.'
reftext: Rosalba Camicia, et al. Mol Cancer. 2015;14:207.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9748692
figid_alias: PMC4676894__F3
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC4676894__F3
ndex: 8d1e784d-dec1-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4676894__12943_2015_474_Fig3_HTML.html
  '@type': Dataset
  description: 'Oncogenic (deregulated) intracellular signaling pathways in activated
    B cell-like (ABC) diffuse large B-cell lymphoma (DLBCL). The oncogenic constitutive
    activation of canonical nuclear factor-kappa B (NF-κB) family members in activated
    B cell-like diffuse large B-cell lymphoma (ABC-DLBCL), together with a blockade
    in terminal B cell differentiation, which is in part mediated by BCL6, represent
    the hallmarks of ABC-DLBCL pathogenesis [, –, ]. The different colors that are
    used in the figure indicate molecules that belong to a specific pathway and/or
    lead to a specific outcome. Adapted from REF: [, , , ]. Information for this figure
    was gleaned from the following references: [, , , , –, , , , , , –, , , , , ,
    –, , , , , , , , , , , , , –, –, , , , , –, –, –, , , , , –, –, , , ]. Abbreviations:
    BCR B cell receptor, BTK Bruton’s tyrosine kinase, SYK spleen tyrosine kinase,
    PI3K phosphoinositide 3-kinase, mTORC1 mammalian target of rapamycin (mTOR) complex
    1, CD40L CD40 ligand, JAK Janus kinase, IRF4 interferon-regulatory factor 4, MALT1
    mucosa-associated lymphoid tissue lymphoma translocation protein 1, BCL10 B cell
    lymphoma protein 10, TLR Toll-like receptor, MyD88 myeloid differentiation primary
    response 88, CARD11 caspase recruitment domain family, member 11, PKCβ protein
    kinase Cβ, STAT3 signal transducer and activator of transcription 3, BCL6 B cell
    lymphoma protein 6, BCL2 B cell lymphoma protein 2'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BCR
  - RN7SL263P
  - MYD88
  - CD40LG
  - CD2
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - CD79A
  - CD79B
  - IL6
  - CD40
  - SYK
  - CD58
  - HLA-A
  - HLA-B
  - HLA-C
  - HLA-E
  - HLA-F
  - HLA-G
  - STAT3
  - CARD11
  - IRAK4
  - IL10
  - BCL10
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MALT1
  - AKT1
  - AKT2
  - AKT3
  - IRF4
  - BCL6
  - EP300
  - NFKB1
  - MTOR
  - RPTOR
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - IFN1@
  - IFNA1
  - IFNA2
  - IFNA17
  - IFNA4
  - IFNA5
  - IFNA6
  - IFNA7
  - IFNA8
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA21
  - MYC
  - TP53
  - TP63
  - TP73
  - BCL2
  - JAK1
  - JAK2
  - Cancer
---
